TP53 and cancer: Over the past decades, p53-based cancer therapeutic strategies have mainly focused on p53 gene-transfer therapy with an adenovirus vector, or on restoring p53 activity using small molecule drugs that interact with mutant p53 protein and alter the conformation of the protein [59].